vimarsana.com

Stoke Therapeutics to Present Data from the Company's Dravet Syndrome Program at the American Epilepsy Society 2022 Annual Meeting

Stoke Therapeutics to Present Data from the Company's Dravet Syndrome Program at the American Epilepsy Society 2022 Annual Meeting
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

Related Keywords

Santiago , Regióetropolitana , Chile , United States , Tennessee , United Kingdom , Massachusetts , Bedford , Cambridge , Cambridgeshire , Michigan , Chicago , Illinois , American , Kimberly Parkerson , Helen Cross , Joseph Sullivan , Barry Ticho , Colin Roberts , Luis Lopez , Ann Roberth Lurie , Eric Rojas , Linda Laux , International League Against Epilepsy , American Epilepsy Society , Biomarker Development At Stoke Therapeutics , Company Dravet , Augmentation Of Nuclear Gene Output , Stoke Therapeutics Inc , Nasdaq , Northwestern University Feinberg School Of Medicine , Exchange Commission , Company Annual Report On Form , Details For The Company , Wall Street , Chief Medical Officer , United Kingdom Study Investigating , Antisense Oligonucleotide , Dravet Syndrome , Childhood Epilepsy , Developmental Neuroscience Programme , Child Health , Honorary Consultant , Paediatric Neurology , Investigating Safety , Drug Exposure , Associate Professor , Northwestern University Feinberg School , Attending Physician , Previously Participated , Doernbecher Childhood Epilepsy Program , Oregon Health , Science University , Predict Pharmacological Active Dose , Senior Vice President , Biomarker Development , Stoke Therapeutics , Twelve Month Analysis , Investigate Cognition , Vice President , Neurology Clinical Development , Parvalbumin Positive Fast Spiking Interneurons , Mouse Model , Luis Lopez Santiago , Associate Research Scientist , Michigan Medical School , Targeted Augmentation , Nuclear Gene Output , Private Securities Litigation Reform Act , Annual Report , Quarterly Reports , Investor Contacts , Investor Relations ,

vimarsana.com © 2020. All Rights Reserved.